Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling.

Roh JD, Sawh-Martinez R, Brennan MP, Jay SM, Devine L, Rao DA, Yi T, Mirensky TL, Nalbandian A, Udelsman B, Hibino N, Shinoka T, Saltzman WM, Snyder E, Kyriakides TR, Pober JS, Breuer CK.

Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4669-74. doi: 10.1073/pnas.0911465107. Epub 2010 Mar 5.

2.

Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion.

Huang NF, Niiyama H, Peter C, De A, Natkunam Y, Fleissner F, Li Z, Rollins MD, Wu JC, Gambhir SS, Cooke JP.

Arterioscler Thromb Vasc Biol. 2010 May;30(5):984-91. doi: 10.1161/ATVBAHA.110.202796. Epub 2010 Feb 18.

3.

Late-term results of tissue-engineered vascular grafts in humans.

Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, Shinoka T.

J Thorac Cardiovasc Surg. 2010 Feb;139(2):431-6, 436.e1-2. doi: 10.1016/j.jtcvs.2009.09.057.

4.

Cell-seeding techniques in vascular tissue engineering.

Villalona GA, Udelsman B, Duncan DR, McGillicuddy E, Sawh-Martinez RF, Hibino N, Painter C, Mirensky T, Erickson B, Shinoka T, Breuer CK.

Tissue Eng Part B Rev. 2010 Jun;16(3):341-50. doi: 10.1089/ten.TEB.2009.0527. Review.

5.

In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model.

Nieponice A, Soletti L, Guan J, Hong Y, Gharaibeh B, Maul TM, Huard J, Wagner WR, Vorp DA.

Tissue Eng Part A. 2010 Apr;16(4):1215-23. doi: 10.1089/ten.TEA.2009.0427.

6.

Endothelial progenitor cells and their potential therapeutic applications.

Khoo CP, Pozzilli P, Alison MR.

Regen Med. 2008 Nov;3(6):863-76. doi: 10.2217/17460751.3.6.863. Review.

PMID:
18947309
7.

Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.

Brennan MP, Dardik A, Hibino N, Roh JD, Nelson GN, Papademitris X, Shinoka T, Breuer CK.

Ann Surg. 2008 Sep;248(3):370-7. doi: 10.1097/SLA.0b013e318184dcbd.

8.

Generation of functional murine cardiac myocytes from induced pluripotent stem cells.

Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler J, Hasenfuss G, Martin U.

Circulation. 2008 Jul 29;118(5):507-17. doi: 10.1161/CIRCULATIONAHA.108.778795. Epub 2008 Jul 14.

9.

Gene and stem cell therapy in peripheral arterial occlusive disease.

Kalka C, Baumgartner I.

Vasc Med. 2008;13(2):157-72. doi: 10.1177/1358863x08088616. Review.

PMID:
18593804
10.

Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages.

Schenke-Layland K, Rhodes KE, Angelis E, Butylkova Y, Heydarkhan-Hagvall S, Gekas C, Zhang R, Goldhaber JI, Mikkola HK, Plath K, MacLellan WR.

Stem Cells. 2008 Jun;26(6):1537-46. doi: 10.1634/stemcells.2008-0033. Epub 2008 May 1.

11.

Stem-cell therapy for cardiac disease.

Segers VF, Lee RT.

Nature. 2008 Feb 21;451(7181):937-42. doi: 10.1038/nature06800. Review.

PMID:
18288183
12.

Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.

Spinetti G, Kraenkel N, Emanueli C, Madeddu P.

Cardiovasc Res. 2008 May 1;78(2):265-73. doi: 10.1093/cvr/cvn039. Epub 2008 Feb 15. Review.

13.

Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.

Roh JD, Nelson GN, Brennan MP, Mirensky TL, Yi T, Hazlett TF, Tellides G, Sinusas AJ, Pober JS, Saltzman WM, Kyriakides TR, Breuer CK.

Biomaterials. 2008 Apr;29(10):1454-63. doi: 10.1016/j.biomaterials.2007.11.041. Epub 2007 Dec 27.

14.

Reprogramming of human somatic cells to pluripotency with defined factors.

Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ.

Nature. 2008 Jan 10;451(7175):141-6. Epub 2007 Dec 23.

PMID:
18157115
15.

Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S.

Cell. 2007 Nov 30;131(5):861-72.

16.

Induced pluripotent stem cell lines derived from human somatic cells.

Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA.

Science. 2007 Dec 21;318(5858):1917-20. Epub 2007 Nov 20.

17.

Reconstruction of functional tissues with cell sheet engineering.

Yang J, Yamato M, Shimizu T, Sekine H, Ohashi K, Kanzaki M, Ohki T, Nishida K, Okano T.

Biomaterials. 2007 Dec;28(34):5033-43. Epub 2007 Aug 29. Review.

PMID:
17761277
18.

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE.

Nat Biotechnol. 2007 Sep;25(9):1015-24. Epub 2007 Aug 26.

PMID:
17721512
19.

Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo.

Ferreira LS, Gerecht S, Shieh HF, Watson N, Rupnick MA, Dallabrida SM, Vunjak-Novakovic G, Langer R.

Circ Res. 2007 Aug 3;101(3):286-94. Epub 2007 Jun 14.

20.

Generation of germline-competent induced pluripotent stem cells.

Okita K, Ichisaka T, Yamanaka S.

Nature. 2007 Jul 19;448(7151):313-7. Epub 2007 Jun 6.

PMID:
17554338

Supplemental Content

Support Center